Top Markets
#1 Zora Zora +36.32%
#2 AI XOVIA AI XOVIA +31.92%
#3 Full Moon Full Moon +19.37%
#4 Notcoin Notcoin +15.94%
#5 0G 0G +15.52%
#6 Axelar Axelar +12.94%
#7 Wrapped NXM Wrapped NXM +12.69%
#8 rsERG rsERG +12.06%
#9 Seeker Seeker +11.21%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +10.43%
Coin of the day
Zora Zora
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Equasens S.A. Equasens S.A.

Equasens S.A.

EQS
Classificação em ações #12342
Equasens S.A., established in 1996 and headquartered in Villers-les-Nancy,... Equasens S.A., established in 1996 and headquartered in Villers-les-Nancy, France, delivers a diverse portfolio of information technology solutions tailored for the European healthcare industry. The company primarily equips pharmacies and their networks with advanced management systems, including LGPI global services and OffiCentral. Pharmacists leverage a comprehensive suite of tools designed to streamline daily business operations, such as OffiMSS, OffiSecure, OffiProtect, OffiPass, OffiSeen, OffiCash, Offizzy, and OffiLocker. To foster stronger customer relationships and engagement, Equasens provides innovative solutions like OffiTag, OffiTouch, OffiMédia, OffiConnect, alongside automation systems and loyalty program management. Beyond operational software, the company offers analytical insights through its My Pilot tool and professional development opportunities via OffiLearning, an e-learning platform. A key area of focus is patient support, with offerings spanning compliance monitoring software, Multimeds, Automeds, OffiTéléconsult, and essential pharmaceutical and shared medical record services. The company's specialized systems include ULTIMATE, which combines efficient pharmacy administration with enhanced patient care, and FARMACLICK, a protocol facilitating communication between pharmacies and wholesale distributors (the latter also served by DIFARM). Additional retail management tools comprise PHARE and the SOPHIA pharmacy application, complemented by OffiMédia POS displays. Equasens also addresses specific health needs, such as chronic renal failure management with eNephro, and simplifies the administration of patient education programs through TPE Pilot. Further extending its reach across the healthcare sector, Equasens offers various dedicated solutions like NOVIACARE, CARELIB (for home and nursing home care), KAPELSE, TITAN, ANTHADINE software, the MOBISOINS mobile tool, MICROSOINS for in-home nursing care, and LOGICLIC. For holistic patient journey oversight, the AXIGATE solutions and CHORUS platform are available. Supplementary services include medical telesecretarial assistance for healthcare professionals and equipment lease financing options. Equasens S.A. functions as a subsidiary of Marque Verte Sante.
Preço da ação
$39.62
Última sincronização: 2026-08-28
Valor de mercado
$595.54M
Variação (1 dia)
0.60%
Variação (1 ano)
-25.89%
País
FR
Negociar Equasens S.A. (EQS)

Categoria

Technology
Rácio P/E de Equasens S.A. (EQS)
Rácio P/E em 2026 TTM: 0
De acordo com os últimos relatórios financeiros e o preço das ações da Equasens S.A., o rácio P/E atual (TTM) é 0. No final de 2026, a empresa tinha um P/E de 0.
Histórico do rácio P/E da Equasens S.A. de 2026 a 2026
Rácio P/E no final de cada ano
Ano Índice P/E Alterar
Não há dados suficientes para as datas fornecidas.
Rácio P/E para empresas semelhantes ou concorrentes
Empresa Rácio P/E Diferença do rácio P/E País
SAP SE SAP SE
SAP SE
SAP.DE
 27.13 -
DE
Salesforce, Inc. Salesforce, Inc.
Salesforce, Inc.
CRM.US
 22.63 -
US
Shopify Inc. Shopify Inc.
Shopify Inc.
SHOP.TO
 - -
CA
Uber Technologies, Inc. Uber Technologies, Inc.
Uber Technologies, Inc.
UBER.US
 16.40 -
US
ServiceNow, Inc. ServiceNow, Inc.
ServiceNow, Inc.
NOW.US
 77.02 -
US
Como interpretar um P/E Ratio?

O rácio Preço/Lucro (P/E) mede a relação entre o preço da ação de uma empresa e o lucro por ação.
Um P/E baixo mas positivo representa uma empresa com altos lucros face à sua valorização atual e pode estar subvalorizada. Um P/E negativo elevado (perto de 0) representa perdas significativas.

Empresas com P/E acima de 30 ou negativo são geralmente vistas como "ações de crescimento", significando que os investidores esperam crescimento ou rentabilidade futura.

Empresas com P/E positivo inferior a 10 são geralmente consideradas "ações de valor", ou seja, já são muito lucrativas mas com pouco potencial de crescimento.